Menu
GeneBe

rs562147027

Variant summary

Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6

The NM_001036.6(RYR3):c.17A>G(p.Glu6Gly) variant causes a missense change. The variant allele was found at a frequency of 0.000191 in 1,582,534 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00027 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00018 ( 0 hom. )

Consequence

RYR3
NM_001036.6 missense

Scores

1
5
9

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: 6.92
Variant links:
Genes affected
RYR3 (HGNC:10485): (ryanodine receptor 3) The protein encoded by this gene is a ryanodine receptor, which functions to release calcium from intracellular storage for use in many cellular processes. For example, the encoded protein is involved in skeletal muscle contraction by releasing calcium from the sarcoplasmic reticulum followed by depolarization of T-tubules. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -3 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.009333372).
BP6
Variant 15-33311062-A-G is Benign according to our data. Variant chr15-33311062-A-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 531143.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=1}.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
RYR3NM_001036.6 linkuse as main transcriptc.17A>G p.Glu6Gly missense_variant 1/104 ENST00000634891.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
RYR3ENST00000634891.2 linkuse as main transcriptc.17A>G p.Glu6Gly missense_variant 1/1041 NM_001036.6 P4Q15413-1

Frequencies

GnomAD3 genomes
AF:
0.000270
AC:
41
AN:
151940
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00836
Gnomad EAS
AF:
0.00156
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000454
AC:
100
AN:
220478
Hom.:
0
AF XY:
0.000504
AC XY:
61
AN XY:
121102
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000327
Gnomad ASJ exome
AF:
0.00845
Gnomad EAS exome
AF:
0.000708
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000888
Gnomad OTH exome
AF:
0.000390
GnomAD4 exome
AF:
0.000183
AC:
262
AN:
1430476
Hom.:
0
Cov.:
30
AF XY:
0.000184
AC XY:
131
AN XY:
711212
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000242
Gnomad4 ASJ exome
AF:
0.00757
Gnomad4 EAS exome
AF:
0.000555
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000255
Gnomad4 OTH exome
AF:
0.000356
GnomAD4 genome
AF:
0.000270
AC:
41
AN:
152058
Hom.:
0
Cov.:
32
AF XY:
0.000229
AC XY:
17
AN XY:
74330
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00836
Gnomad4 EAS
AF:
0.00156
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000588
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.00104
Hom.:
0
Bravo
AF:
0.000238
ExAC
AF:
0.000381
AC:
46

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsApr 14, 2022The c.17A>G (p.E6G) alteration is located in exon 1 (coding exon 1) of the RYR3 gene. This alteration results from a A to G substitution at nucleotide position 17, causing the glutamic acid (E) at amino acid position 6 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Epileptic encephalopathy Benign:1
Likely benign, criteria provided, single submitterclinical testingInvitaeNov 17, 2020- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.10
T
BayesDel_noAF
Uncertain
-0.010
Cadd
Uncertain
24
Dann
Uncertain
1.0
DEOGEN2
Benign
0.23
T;.;.;.;.
Eigen
Benign
0.011
Eigen_PC
Benign
0.17
FATHMM_MKL
Uncertain
0.89
D
LIST_S2
Benign
0.74
T;T;T;T;T
M_CAP
Pathogenic
0.52
D
MetaRNN
Benign
0.0093
T;T;T;T;T
MetaSVM
Uncertain
0.66
D
MutationAssessor
Benign
1.0
L;L;.;.;.
MutationTaster
Benign
0.79
D;D
PrimateAI
Uncertain
0.61
T
Polyphen
0.32
B;B;.;.;.
Vest4
0.49
MVP
0.47
MPC
0.21
ClinPred
0.099
T
GERP RS
5.2
Varity_R
0.20
gMVP
0.29

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs562147027; hg19: chr15-33603263; COSMIC: COSV105326333; COSMIC: COSV105326333; API